The Ossoliński family (Anna Ossolińska, Krzysztof Ossoliński, and Tadeusz Ossoliński) is distinguished by its collective contributions to academic medicine, particularly in urology, oncology, and mass spectrometry-based biomarker research. Their combined body of work includes over 33 peer‑reviewed publications, and their research has been cited nearly 800 times globally:
- Krzysztof Ossoliński: 33 publications, over 469 citations
- Anna Ossolińska: 24 publications, over 300 citations
- Tadeusz Ossoliński: 21 publications, over 273 citations
Their studies are conducted in collaboration with teams from John Paul II District Hospital in Kolbuszowa and Rzeszów University of Technology, under the leadership of professors and chemists such as Joanna Nizioł, Tomasz Ruman, Valérie Copié, Brian Tripet, and others.
Together, they have pioneered innovative analyses in metabolomics, mass spectrometry imaging, nanoparticle-enhanced LDI‑MS, and blood/urine metabolic profiling across renal and bladder cancers. Their research excellence has earned recognition from international journals, including Scientific Reports, Metabolomics, Analytical Sciences, and Advances in Medical Sciences.
Below is a carefully curated selection showcasing their most impactful publications, underscoring their dedication to advancing non‑invasive diagnostics, biomarker discovery, and personalized medicine.